Browse By: Country ι Category ι Latest Reports ι Tag

Membrane Bioreactor (MBR) Systems Market By Configuration (Sidestream And Submerged) For Product (Hollow Fiber, Flat Sheet And Multi-Tubular Systems) In Applications (Municipal Wastewater And Industrial Wastewater) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2019

Pages » 110
Published By » Transparency Market Research
Price » $4795
In stock
View Report Details
Description

Membrane Bioreactor (MBR) is a relatively new yet fast maturing technology in the area of wastewater treatment. Prevalent technologies in wastewater treatment such as conventional activated sludge (CAS) systems are gradually replaced by MBR. Conventional systems had problems in settling the activated sludge used in the secondary clarifiers. This issue has been effectively resolved by MBR technology. Commercial MBR processes employed today utilize membranes for filtration purposes which reject any solid effluent materials formed as a byproduct of biological processes. The principal differentiation with its predecessor technology such as CAS systems is the replacement of secondary clarifier... Click here for more details


Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
GBI Research\'s report, “Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies”, provides the key data and analyzes the major challenges and drivers for the biomanufact
Published Date: Sep 2010
Price: $3500
Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth
GBI Research, the leading business intelligence provider, has released its latest report, “Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth” that provides key data, information and analysis of the major trends and issues affecti
Published Date: Sep 2010
Price: $3500
Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential” that provides key data, information and analysis of the major trends and issues in
Published Date: Dec 2010
Price: $3500
Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
GBI Research, the leading business intelligence provider, has released its latest report, “Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions” that provides key data, information and analysis of the major trends and
Published Date: Dec 2010
Price: $3500
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
GBI Researchs new report, Early Stage Drug Development in Disease Segments Innovation Focuses on Stem Cell Therapies and Gene Therapies, provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immu
Published Date: Feb 2011
Price: $3500
Biobanks - 2011 Yearbook
GBI Research, the leading business intelligence provider, has released its latest research, Biobanks - 2011 Yearbook. It provides key data, information and analysis of the 40 major biobanks in the world. The report provides information on the population-based biobanks, disease based biobanks, brai
Published Date: Mar 2011
Price: $3500
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
GBI Research, the leading business intelligence provider, has released its latest research Clinical Trial Endpoints in Oncology Inclusion of Surrogate Endpoints and Shorter Endpoints will Ensure Faster Clinical Trials in Oncology, which essentially provides insights into clinical trial endpoints i
Published Date: Mar 2011
Price: $3500
Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
GBI Research, the leading business intelligence provider, has released its latest report, Biosimilars Approval Pathways in the US and Europe Development and Approval of Biosimilar mAbs May Face Tough Regulatory Environment that provides key data, information and analysis of the major trends and is
Published Date: Apr 2011
Price: $3500
Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars
GBI Research, the leading business intelligence provider, has released its latest research, Cancer Supportive Care Products Market to 2016 Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars, which provides insights into the cancer supportive care products mark
Published Date: Apr 2011
Price: $3500
Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics
GBI Researchs new report, Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics provides key data, information and analysis on the Orthobiologics industry and analytical content on the market dynamics. The report provides mar
Published Date: Jun 2011
Price: $3500

 


 

Related News

Largest Petrochemical Company in China Records Profit in the First Quarter of 2015
China’s largest petrochemical company, Shanghai Petrochemicals announced its results for the first quarter of 2015. According to Mr. Wang Zhiqing, the chairman of Shanghai Petrochemicals, the group has recorded profit in the first quarter of this year compared to the losses registered during the same duration last year. Mr. Wang mentioned that the profit was due to the low prices of international crude oil, which resulted in the lower cost for oil processing and increase in the gross profi
Date: Apr 24

Price of Iron Ore in China Trades near a One-Month High
Increase in steel production has led to the steady increase of the price of iron ore in China. The Steel Index revealed that since the last closure session at US$52.90 a tonne, the price of iron ore jumped 1.7 percent to US$53.80 tonne in the latest session. Earlier this month, the price of iron ore hit the lowest in 10 years at US$46.70. The current price soar reflects 15 percent increase to the lowest recorded mark.  The price recovery is a result of the Chinese government’s pers
Date: Apr 24

World’s Leading Copper Producer Sells Mixed Copper Blends to Chinese Smelters
Revealed by a source at the Chilean state-owned mine Codelco, the company has been selling mixed copper blends to the copper smelters from China without facing any problem. The company’s Ministro Hales mine has copper with high-arsenic content which it mixes with the cleaner copper grades to sell to the Chinese smelters.  In China, import of materials containing more than 0.5 percent arsenic has been restricted. However, the source at Codelco said that Chinese smelters have been ta
Date: Apr 24

Food Trucks to Include Spam in Their Offerings
During the economic slowdown, Spam had been off the stores; however, when the economy has improved, canned and pre-cooked pork of Hormel Foods’ is hoping for some new and higher brow market. From 2009, the product has been playing a small part in the haute cuisine, since the LA eatery Animal; Vinny Dotolo paired it along with foie gras. In the year 2011, Chef Hooni Kim used it in a stew at his Danji restaurant in New York. In the previous April, Gothamist has given a report which stated th
Date: Apr 23

A Listed Australian Company Makes Effort to Penetrate the Chinese Candy Crush Market
One of the Australian listed resources company is planning to acquire a huge stake in one of the food groups in China which will bear exclusive rights for manufacturing and distributing the widely-known Candy Crush brand products across China. Resource Star (RSL) which is a mineral and a rare earth explorer which has a market capitalization of around US$6.44 million along with a share price of 1 cent, has agreed with due conditions to take over about 60% stake in the Sugar Dragon company at a
Date: Apr 23

Americans Has a Huge Issue with Food Wasting Tendency
For an average American throwing away an amount of US$2,000 in a year is not a big issue and apparently one may not even be much aware of it. As per a research study conducted by the Natural Resources Defense Council (NRDC), in every year Americans throw away an amount of US$165 billion approximately on food each year and talking about an average family in America reaches up to around US$2,200 per family. As per the recent findings of the Environmental Protection Agency, this numbers overall
Date: Apr 23

China to Open Up for Foreign Card Companies
China has formally announced its plans for opening up its market for clearing the transactions of domestic bank card. The move has been taken to allow foreign entities such as MasterCard Inc and Visa Inc get direct access to the lucrative market of China, worth US$6.84 trillion as per the estimates of the last year.  The regulatory reform introduced by the Chinese government will enable foreign firms to establish their own clearing companies across China as well as apply for license for
Date: Apr 23

Europe is Expecting Deutsche Bank to Emerge as the Champion
Deutsche Bank has come across as the last most promising contender. At a time when all other investment banks in Europe, such as UBS, Barclays, and Credit Suisse are retreating to retail and private banking amid the discontent of investors and stringent regulatory norms, Deutsche Bank is doing the opposite. Industry experts believe it is aiming to emerge like Goldman Sachs, and nothing less.  Chief Executive of Barclays, Antony Jenkins, declared last month that he dint have much patience
Date: Apr 23

Financial Service Council Took to Clean-up its Tainted Image in the Insurance Industry
As revealed by Sally Laone, the new boss of the Financial Services Council, the industry of life insurance is all set to meet the six week deadline laid down by the federal government to respond concerns pertaining to the troubled insurance sector in Australia, and will provide answers expected from  the industry to clean its tainted image. Ms Laone, who was also the former radio presenter for ABC, later took over the John Brogden in December said, it was one of her priorities to table a
Date: Apr 23

Aramark President Addressed Issues Related to Food Served at Kauffman Stadium
Officials working with Aramark, which is one of the leading firms operating concessions at Arrowhead and Kauffman stadiums and other prominent sports venue across the United States met at the Kauffman Stadium on Tuesday. The officials came together to address concerns related to food safety and quality.  The news conference organized by the officials included a tour of the main kitchen as well as the concession stands. Several changes implemented by Aramark to avoid the violation of any
Date: Apr 22

Upcoming Reports

Hormone Replacement Therapy Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Hormone replacement therapy (HRT) is administration of hormones to those patients who are under a phase of declining natural hormones in their body. Hormone replacement therapy is mostly administered to women undergoing menopausal phase. The hormones which are administered to patients are most
Published By: Transparency Market Research
Price: $4795
Bio-Implants Market - Global Industry Analysis, Market Size, Market Share And Forecast, 2012 - 2018
Bio-implants are bioengineered products known to be of human or animal origin used in the different fields of ENT. Generally, these bio-implants are offered for safeguarding after tissue replacement. These bio-implants are made up of biosynthetic materials known as collagen or it can also be made
Published By: Transparency Market Research
Price: $4795
Biobanks Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Biobanks is a collection or storation of blood and cell samples from a large number of people. Biobank collection denotes its use in medical field and research. The global biobank industry is segmented into different sectors such as human tissue banking, or population banking, stem cell banking, c
Published By: Transparency Market Research
Price: $4795
Orthobiological Products Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global orthobiological products market is expected to grow to $15.3 billion by the year 2022 as a result of tremendous growth in the medical devices industry mainly due to increase in aging population. Growth of orthobiological products is driven by increasing awareness towards adoption of ort
Published By: Transparency Market Research
Price: $4795
Gene Amplification Technologies Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
Gene amplification technology is proving to be an important technology in human genome projects and other important fields like diagnostics. There are number of companies involved in the business of gene amplification and diagnostics with over 30 gene and signal amplification technologies. These g
Published By: Transparency Market Research
Price: $4795
DNA Sequencing Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global DNA sequencing market is forecast to grow to $6.6 billion over the year 2016 at the compounded annual growth rate of 17.5% as a result of emerging technologies in this field and its use in a number of applications.   DNA sequencing industry is segmented into instruments and consu
Published By: Transparency Market Research
Price: $4795
Epigenetics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global epigenetics market is projected to reach the value of $18.2 billion by the year 2015 driven by investigation of factors influencing cellular malfunction and disease development. Also, developments in epigenetic studies like biomarker discovery and scientifically useful biomarker tests a
Published By: Transparency Market Research
Price: $4795
Biologics Market - G7 Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
With an increase in the number of clinical trials in the past 5 years, the market for biologics is expected to witness a high growth during the coming years. Monoclonal antibodies, vaccines and therapeutic proteins will contribute significantly to the growth in the biologics market. The global
Published By: Transparency Market Research
Price: $4795
Biosimilar and Follow-On Biologics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new heights. Drug manufacturers are exploring the possibilities of producing generic biopharmaceuticals drugs with a motive of reducing the prices of thes
Published By: Transparency Market Research
Price: $4795
Biopesticides Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
Biopesticides are essential for controlling the effect of agricultural pests, insects, and bacterial and fungal growth on food and field crops. Use of biopesticides can avoid the hazards caused by the use of chemical pesticides on the environment. Growing environmental concerns and stringent r
Published By: Transparency Market Research
Price: $4795